Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease

Author(s): Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, et al.


Objectives: To quantify the overall contribution of mutations in the currently known amyotrophic lateral sclerosis (ALS) genes in a large cohort of sporadic patients and to make genotype–phenotype correlations.

Methods: Screening for SOD1, TARDBP, FUS, ANG, ATXN2, OPTN, and C9ORF72 was carried out in 480 consecutive patients with sporadic ALS (SALS) and in 48 familial ALS (FALS) index patients admitted to a single Italian referral center.

Results: Mutations were detected in 53 patients, with a cumulative frequency of 11. Seven of them were novel. The highest frequencies of positive cases were obtained in TARDBP (2.7%), C9ORF72 (2.5%), and SOD1 (2.1%). The overall group of mutated patients was indistinguishable from that without mutations as no significant differences were observed with regard to age and site of onset, frequency of clinical phenotypes, and survival. However, by separately evaluating genotype–phenotype correlation in single genes, clinical differences were observed among different genes. Duration of disease was significantly shorter in patients harboring the C9ORF72 expansion and longer in the SOD1 group. A high frequency of predominant upper motor neuron phenotype was observed among patients with TARDBP mutations. Two patients, 1 with C9ORF72 and 1 with SOD1 mutation, had concurrent ANG mutations. Mutations were detected in 43.7% of patients with FALS.

Conclusions: A considerable proportion of patients with SALS harbored mutations in major ALS genes. This result has relevant implications in clinical practice, namely in genetic counseling. The detection of double mutations in 2 patients raises the hypothesis that multiple mutations model may explain genetic architecture of SALS. Neurology®

Similar Articles

Amyotrophic Lateral Sclerosis – Frontotemporal Spectrum Disorder (ALS-FTSD): Revised diagnostic criteria

Author(s): Strong MJ, Abrahams S, Goldstein LH, Wooley S, Mclaughlin P, et al.

Genetic counselling in ALS: facts, uncertainties and clinical suggestions

Author(s): Chiò A, Battistini S, Calvo A, Caponnetto C, Conforti FL, et al.

New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis

Author(s): Sabatelli M, Marangi G, Conte A, Tasca G, Zollino M, et al.

ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis

Author(s): Lattante S, Pomponi MG, Conte A, Marangi G, Bisogni G, et al.

Pathological laughing and crying in amyotrophic lateral sclerosis

Author(s): McCullagh S, Moore M, Gawel M, Feinstein A

The El Escorial criteria: strengths and weakessnes

Author(s): Agosta F, Al-Chalabi A, Filippi M, Hairdman O, Kaji R, et al.

Cognitive changes predict functional decline in ALS: a polupaltion-based longitudinal study

Author(s): Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, et al.

Cognitive functioning in sporadic amyotrophic lateral sclerosis: A six month longitudinal study

Author(s): Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, et al.

Premorbid personality characteristics of patients with ALS

Author(s): Grossman AB, Bonnie EL, Bradley WG

Emotional Adjustment in Amyotrophic Lateral Sclerosis (ALS)

Author(s): Lulè D, Paulì S, Altinas E, Singer U, Mèrk T, et al.

Prevalence of Fatigue and depression in ALS patients and change over time

Author(s): McElhiney MC, Rabkin JC, Gordon PH, Goetz R, Mitsumoto H

Deficits in emotional and social cognition in Amyotrophic Lateral Sclerosis

Author(s): Girardi A, MacPherson SE, Abrahams S

Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum

Author(s): Lillo P, Savage S, Mioshui E, Kiernan MC, Hodges JR

La diagnosi in psichiatria

Author(s): Frances A

The cognitive profiles of ALS: A systematic review and meta-analisis update

Author(s): Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, et al.

Functional scales and motor assessment in Amyotrophic Lateral Sclerosis

Author(s): Benaim C, Desnuelle C, Fourniere-Mehouas M

The Amyotrophic Lateral Sclerosis Functional Rating Scale

Author(s): ALS CNTF Treatment Study (ACTS) Phase I-II Study Group

The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

Author(s): Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, et al.